Key result
This review outlines the definitions, risk assessment, preventive strategies, and management of major and minor bleeding complications associated with oral anticoagulant therapy.
This review outlines the definitions, risk assessment, and management strategies for bleeding complications associated with oral anticoagulant therapy.
Offers clinicians a structured overview of OAC bleeding management; leaves open gaps requiring prospective validation.
The frequency of anticoagulant-related bleeding has been reported to range 1-7% per year, depending on the indication for anticoagulant therapy and the classification of bleeding. Although most bleeding is not life threatening, it does cause short-term morbidity and inconvenience to patients, as well as possibly diminishing their quality of life to some degree. Assessing the risk of anticoagulant-related bleeding is integral to optimising the management of anticoagulant therapy. Furthermore, early recognition and treatment of anticoagulant-related bleeding can reduce the associated morbidity. This article reviews the definitions of major and minor bleeding, the assessment of risk and preventive strategies and the management of anticoagulant-related bleeding.
No takes yet. Share an insight, caveat, or question.
Rebecca J. Beyth (2002) conducted a review in Anticoagulant-related bleeding. Management of anticoagulant-related bleeding was evaluated. This review outlines the definitions, risk assessment, preventive strategies, and management of major and minor bleeding complications associated with oral anticoagulant therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: